Physiological modes of action of fluoxetine and its human metabolites in algae

Environmental Science and Technology

Volumn 43, Issue 17, 2009, Pages 6830-6837

  Neuwoehner, Judith ^a,b   Fenner, Kathrin ^a,b   Escher, Beate I ^a,c  

^a SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE INGREDIENTS; ACTIVE METABOLITES; ALGAL CELLS; CONCENTRATION ADDITION; DAPHNIA; DIFFERENT EFFECTS; ENERGY BUDGETS; FLUOXETINE; HUMAN METABOLITES; LITERATURE DATA; MIXTURE TOXICITY; MODE OF ACTION; NORFLUOXETINE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS; REFERENCE COMPOUNDS; TIME DEPENDENCE; WATER PARTITION COEFFICIENTS;

BIOMOLECULES; METABOLISM; METABOLITES; PHYTOPLANKTON; RISK ASSESSMENT; RISK MANAGEMENT; SULFUR COMPOUNDS;

TOXICITY;

FLUOXETINE; LIPOSOME; NORFLUOXETINE; WATER;

ALGA; ENERGY BUDGET; GROWTH RATE; METABOLITE; PHYSIOLOGY; RISK ASSESSMENT; TOXICITY TEST;

ALGA; ARTICLE; CONTROLLED STUDY; ENERGY; METABOLITE; PARTITION COEFFICIENT; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SENSITIVITY ANALYSIS; TOXICITY;

FLUOXETINE; HUMANS; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SCENEDESMUS; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL;

ALGAE; DAPHNIA;

EID: 69549106429     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es9005493     Document Type: Article

References (52)

1. Traboulsie, A.; Chemin, J.; Kupfer, E.; Nargeot, J.; Lory, P. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol. Pharmacol. 2006, 69, 1963-1968. (Pubitemid 43894314)
2. Altamura, A. C.; Moro, A. R.; Percudani, M. Clinical pharmacokinetics of fluoxetine. Clin. Pharmacokinet. 1994, 26, 201-214.
3. Lemberger, L.; Bergstrom, R. F.; Wolen, R. L.; Farid, N. A.; Enas, G. G.; Aronoff, G. R. Fluoxetine - Clinical pharmacology and physiologic disposition. J. Clin. Psychiatry 1985, 46, 14-19.
4. Daughton, C. G.; Ternes, T. A. Pharmaceuticals and personal care products in the environment: agents of subtle change. Environ. Health Perspect. 1999, 107, 907-938.
5. Johnson, D. J.; Sanderson, H.; Brain, R. A.; Wilson, C. J.; Bestari, K. T.; Solomon, K. R. Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. Reg. Toxicol. Pharmacol. 2005, 42, 313-323. (Pubitemid 41021980)
6. Batt, A. L.; Kostich, M. S.; Lazorchak, J. M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal. Chem. 2008, 80, 5021-5030.
7. Schultz, M. M.; Furlong, E. T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80, 1756-1762.
8. Vanderford, B. J.; Snyder, S. A. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ. Sci. Technol. 2006, 40, 7312-7320. (Pubitemid 44871842)
9. Metcalfe, C. D.; Miao, X. S.; Koenig, B. G.; Struger, J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 2003, 22, 2881-2889. (Pubitemid 37485217)
10. Vasskog, T.; Anderssen, T.; Pedersen-Bjergaard, S.; Kallenborn, R.; Jensen, E. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J. Chromatogr., A 2008, 1185, 194-205.
11. Zorita, S.; Martensson, L.; Mathiasson, L. Hollow-fibre supported liquid membrane extraction for determination of fluoxetine and norfluoxetine concentration at ultra trace level in sewage samples. J. Sep. Sci. 2007, 30, 2513-2521. (Pubitemid 350020052)
12. Stanley, J. K.; Ramirez, A. J.; Chambliss, C. K.; Brooks, B. W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69, 9-16.
13. Brooks, B. W.; Foran, C. M.; Richards, S. M.; Weston, J.; Turner, P. K.; Stanley, J. K.; Solomon, K. R.; Slattery, M.; La Point, T. W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 2003, 142, 169-183.
14. Brooks, B. W.; Turner, P. K.; Stanley, J. K.; Weston, J. J.; Glidewell, E. A.; Foran, C. M.; Slattery, M.; La Point, T. W.; Huggett, D. B. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 2003, 52, 135-142.
15. Christensen, A. M.; Faaborg-Andersen, S.; Ingerslev, F.; Baun, A. Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans. Environ. Toxicol. Chem. 2007, 26, 85-91. (Pubitemid 46174378)
16. Johnson, D. J.; Sanderson, H.; Brain, R. A.; Wilson, C. J.; Solomon, K. R. Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae. Ecotoxicol. Environ. Saf. 2007, 67, 128-139.
17. Escher, B. I.; Baumgartner, R.; Lienert, J.; Fenner, K. Predicting the ecotoxicological effects of transformation products. In Handbook of Environmental Chemistry - Degradation of Synthetic Chemicals in the Environment; Boxall, A. B. A., Ed.; Springer: Heidelberg, Germany, 2008; SpringerLink online, DOI: 89378410.89371007/89376998-89378462-89378015, http://www. springerlink.com/content/48r42t364q183q654/?p= ec460152bfd414906adc89378463e89374997&pi=89378465.
18. Lienert, J.; Gudel, K.; Escher, B. I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ. Sci. Technol. 2007, 41, 4471-4478.
19. Escher, B. I.; Bramaz, N.; Mueller, J. F.; Quayle, P.; Rutishauser, S.; Vermeirssen, E. L. M. Toxic equivalent concentrations (TEQs) for baseline toxicity and specific modes of action as a tool to improve interpretation of ecotoxicity testing of environmental samples. J. Environ. Monit. 2008, 10, 612-621.
20. Altenburger, R.; Walter, H.; Grote, M. What contributes to the combined effect of a complex mixture. Environ. Sci. Technol. 2004, 38, 6353-6362. (Pubitemid 39578650)
21. Neuwoehner, J.; Junghans, M.; Koller, M.; Escher, B. I. QSAR analysis and specific endpoints for classifying the physiological modes of action of biocides in synchronous green algae. Aquat. Toxicol. 2008, 90, 8-18.
22. Faust, M.; Altenburger, R.; Backhaus, T.; Blanck, H.; Boedeker, W.; Gramatica, P.; Hamer, V.; Scholze, M.; Vighi, M.; Grimme, L. H. Predicting the joint algal toxicity of multi-component s-triazine mixtures at low-effect concentrations of individual toxicants. Aquat. Toxicol. 2001, 56, 13-32.
23. Hermens, J. L. M. Quantitative structure-activity relationships of environmental pollutants. In The Handbook of Environmental Chemistry, Reaction and Processes; Hutzinger, J., Ed.; Springer: Berlin, Germany, 1989; Vol.2E, pp 111-162.
24. Verhaar, H. J. M.; Ramos, E. U.; Hermens, J. L. M. Classifying environmental pollutants. 2. Separation of class 1 (baseline toxicity) and class 2 ('polar narcosis') type compounds based on chemical descriptors. J. Chemom. 1996, 10, 149-162.
25. Escher, B. I.; Bramaz, N.; Richter, M.; Lienert, J. Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action based test battery and a QSAR approach. Environ. Sci. Technol. 2006, 40, 7402-7408. (Pubitemid 44871854)
26. Vaes, W. H. J.; Ramos, E. U.; Verhaar, H. J. M.; Hermens, J. L. M. Acute toxicity of nonpolar versus polar narcosis: Is there a difference. Environ. Toxicol. Chem. 1998, 17, 1380-1384.
27. Escher, B. I.; Eggen, R. I. L.; Schreiber, U.; Schreiber, Z.; Vye, E.; Wisner, B.; Schwarzenbach, R. P. Baseline toxicity (narcosis) of organic chemicals determined by membrane potential measurements in energy-transducing membranes. Environ. Sci. Technol. 2002, 36, 1971-1979.
28. Escher, B. I.; Schwarzenbach, R. P. Mechanistic studies on baseline toxicity and uncoupling as a basis for modeling internal lethal concentrations in aquatic organisms. Aquat. Sci. 2002, 64, 20-35.
29. Escher, B. I.; Bramaz, N.; Eggen, R. I. L.; Richter, M. In-vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environ. Sci. Technol. 2005, 39, 3090-3100. (Pubitemid 40638250)
30. Escher, B. I.; Berger, C.; Bramaz, N.; Kwon, J.-H.; Richter, M.; Tsinman, O.; Avdeef, A. Bioavailability, membrane-water partitioning, membrane permability, and baseline toxicity of the parasiticides ivermectin, albendazole and morantel. Environ. Toxicol. Chem. 2008, 27, 909-918.
31. Kaiser, S. M.; Escher, B. I. The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes. Environ. Sci. Technol. 2006, 40, 1784-1791.
32. Vaes, W. H. J.; Ramos, E. U.; Hamwijk, C.; van Holsteijn, I.; Blaauboer, B. J.; Seinen, W.; Verhaar, H. J. M.; Hermens, J. L. M. Solid phase microextraction as a tool to determine membrane/water partition coefficients and bioavailable concentrations in in vitro systems. Chem. Res. Toxicol. 1997, 10, 1067-1072.
33. Balon, K.; Riebesehl, B. U.; Muller, B. W. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res. 1999, 16, 882-888.
34. Nakamura, Y.; Yamamoto, H.; Sekizawa, J.; Kondo, T.; Hirai, N.; Tatarazako, N. The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 2008, 70, 865-873. (Pubitemid 350138543)
35. Yamamoto, H.; Hayashi, A.; Nakamura, Y.; Sekizawa, J. Fate and partitioning of selected pharmaceuticals in aquatic environment. Environ. Sci. 2005, 12, 347-358.
36. Escher, B. I.; Schwarzenbach, R. P.; Westall, J. C. Evaluation of liposome-water partitioning of organic acids and bases. 1. Development of a sorption model. Environ. Sci. Technol. 2000, 34, 3954-3961. (Pubitemid 30745917)
37. Tietjen, K. G.; Kluth, J. F.; Andree, R.; Haug, M.; Lindig, M.; Muller, K. H.; Wroblowsky, H. J.; Trebst, A. The herbicide binding niche of photosystem-II - a model. Pestic. Sci. 1991, 31, 65-72.
38. Krol, E.; Trebacz, K. Ways of ion channel gating in plant cells. Ann. Botany 2000, 86, 449-469. (Pubitemid 30704854)
39. Lenkey, N.; Karoly, R.; Kiss, J. P.; Szasz, B. K.; Vizi, E. S.; Mike, A. The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine. Mol. Pharmacol. 2006, 70, 2052-2063. (Pubitemid 44771921)
40. Mulvaney, A. W.; Spencer, C. I.; Culliford, S.; Borg, J. J.; Davies, S. G.; Kozlowski, R. Z. Cardiac chloride channels: physiology, pharmacology and approaches for identifying novel modulators of activity. Drug Discovery Today 2000, 5, 492-505.
41. Escher, B. I.; Hermens, J. L. M. Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs, and mixture effects. Environ. Sci. Technol. 2002, 36, 4201-4217.
42. Moreland, D. E. Mechanisms of action of herbicides. Ann. Rev. Plant Physiol. Plant Mol. Biol. 1980, 31, 597-638.
43. Hess, F. D. Light-dependent herbicides: An overview. Weed Science 2000, 48, 160-170.
44. Altenburger, R.; Nendza, M.; Schuurmann, G. Mixture toxicity and its modeling by quantitative structure-activity relationships. Environ. Toxicol. Chem. 2003, 22, 1900-1915. (Pubitemid 37337314)
45. Ankley, G. T.; Brooks, B. W.; Huggett, D. B.; Sumpter, J. P. Repeating history: pharmaceuticals in the environment. Environ. Sci. Technol. 2007, 41, 8211-8217.
46. Serjeant, E. P.; Dempsey, B. Ionisation constants of Organic Acids in Aqueous Solution; Pergamon Press: Oxford, England, 1979; Vol.23.
47. Adlard, M.; Okafo, G.; Meenan, E.; Camilleri, P. Rapid estimation of octanol-water partition-coefficients using deoxycholate micelles in capillary electrophoresis. J. Chem. Soc.-Chem. Comm. 1995, 2241-2243.
48. Dollery, C.; Boobis, A. R.; Burley, D.; Davies, D. M.; Davies, D. S.; Harrison, P. I.; Orme, M. L. E.; Park, B. K.; Goldberg, L. I. Therapeutic Drugs; Churchill Livingstone: New York, 1991.
49. Wan, H.; Rehngren, M.; Giordanetto, F.; Bergstrom, F.; Tunek, A. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. J. Med. Chem. 2007, 50, 4606-4615. (Pubitemid 47463235)
50. Hansch, C.; Leo, A.; Hoekman, D. Exploring QSAR. Hydrophobic, Electronic and Steric Constants; American Chemical Society: Washington, DC, 1995.
51. Gulyaeva, N.; Zaslavsky, A.; Lechner, P.; Chlenov, M.; McConnell, O.; Chait, A.; Kipnis, V.; Zaslavsky, B. Relative hydrophobicity and lipophilicity of drugs measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. A simple model for predicting blood-brain distribution. Eur. J. Med. Chem. 2003, 38, 391-396. (Pubitemid 36577189)
52. Giaginis, C.; Theocharis, S.; Tsantili-Kakoulidou, A. Contribution to the standardization of the chromatographic conditions for the lipophilicity assessment of neutral and basic drugs. Anal. Chim. Acta 2006, 573-574, 311-318. (Pubitemid 44088499)